Tag: Agonists

ALPK1 agonists: a new strategy for cancer immunotherapy

ALPK1 agonists: a new strategy for cancer immunotherapy

A recent study by Tian et al.1 in Nature shows that alpha-protein kinase 1 (ALPK1) ...

READ MORE
Agonists for cytosolic bacterial receptor ALPK1 induce antitumour immunity

Agonists for cytosolic bacterial receptor ALPK1 induce antitumour immunity

Ribas, A. et al. SD-101 in combination with pembrolizumab in advanced melanoma: results of a ...

READ MORE